When telephone lines go down, or Internet connections are lost, our communities temporarily come to a halt. What if something similar were found to be happening in Parkinson's? This is the focus of Dr. Schmitz and her team at the PDF Research Center at Columbia University Medical Center.
PDF Grant Programs
Are you interested in furthering Parkinson's science? View PDF's open grant programs.
Improvement in quality-of-life and depressive symptoms during long-term treatment with eslicarbazepine acetate: bia-2093-301 study.
PDF's targeted PubMed search provides you with access to journal articles from the last 90 days that may be pertinent to Parkinson's disease research.
Not what you're looking for? Do you need informational publications about Parkinson's targeted for people living with Parkinson's, caregivers and family members? Please browse PDF's educational materials and programs - which are all available electronically or in print. Order for yourself, a loved one or in bulk for your patients or support group.
J Neurol Neurosurg Psychiatry 2013 Nov; 84(11):e2
Authors: Joyce Cramer, C Elger, P Halasz, D Hodoba, A Czlonkowska, Joana Maia, L Almeida, P Soares-da-Silva
Yale University School of Medicine; University of Bonn; National Institute of Psychiatry and Neurology, Budapest; Clinical Psychiatric Hospital Vrapce, Zagreb; Institute of Psychiatry and Neurology, Warsaw; BIAL-Portela & Co, SA, S Mamede do Coronado, Portugal.
To assess the improvement in quality-of-life and depressive symptoms during long-term adjunctive therapy with eslicarbazepine acetate (ESL) in patients with refractory partial epilepsy.
PMID: 24109079 [PubMed - as supplied by publisher]